CORTCorcept Therapeutics Inc
CORT
Corcept Therapeutics Inc4,428
Mkt Cap
$4.4BVolume
303,194.0052W High
$117.3352W Low
$32.99PE Ratio
45.28CORT Fundamentals
Price
$39.85Prev Close
$39.63Open
$39.8750D MA
$55.06Beta
1.27Avg. Volume
2.69MEPS (Annual)
$1.23P/B
6.59Rev/Employee
$1.35M$5,341.86
Corcept Therapeutics (CORT) Expected to Announce Quarterly Earnings on Wednesday
Corcept Therapeutics (NASDAQ:CORT) will be releasing its Q4 2025 earnings before the market opens on Wednesday, February 25. (View Earnings Report at...
MarketBeat·10h ago
Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2025 Financial Results, Provide Corporate Update and Host Conference Call
Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report fourth quarter and full-year 2025 financial results and provide a corporate update on February 24, 2026. The company...
Business Wire·21h ago
Public Sector Pension Investment Board Raises Stock Position in Corcept Therapeutics Incorporated $CORT
Public Sector Pension Investment Board lifted its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 13.7% during the 3rd quarter, according to its most recent...
MarketBeat·4d ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors...
PR Newswire·6d ago
CORT INVESTIGATION ALERT: Investigation Launched into Corcept Therapeutics (CORT), Hagens Berman Encourages Investors to Contact Firm
CORT INVESTIGATION ALERT: Investigation Launched into Corcept Therapeutics (CORT), Hagens Berman Encourages Investors to Contact Firm CORT INVESTIGATION ALERT: Investigation Launched into Corcept...
PR Newswire·9d ago
Insider Selling: Corcept Therapeutics (NASDAQ:CORT) Insider Sells 20,000 Shares of Stock
Corcept Therapeutics Incorporated (NASDAQ:CORT - Get Free Report) insider William Guyer sold 20,000 shares of the business's stock in a transaction that occurred on Tuesday, February 3rd. The stock...
MarketBeat·12d ago
Corcept Therapeutics (NASDAQ:CORT) Insider Sells 20,000 Shares
Corcept Therapeutics Incorporated (NASDAQ:CORT - Get Free Report) insider William Guyer sold 20,000 shares of Corcept Therapeutics stock in a transaction dated Tuesday, February 3rd. The shares were...
MarketBeat·13d ago
CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm
CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud...
PR Newswire·13d ago
Corcept Therapeutics Incorporated Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - CORT
Corcept Therapeutics Incorporated Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - CORT Corcept Therapeutics Incorporated Investigated on Behalf of Investors...
PR Newswire·13d ago
Corcept Therapeutics Incorporated (NASDAQ:CORT) Given Average Rating of "Hold" by Brokerages
Corcept Therapeutics Incorporated (NASDAQ:CORT - Get Free Report) has received an average rating of "Hold" from the eight research firms that are currently covering the firm, MarketBeat Ratings...
MarketBeat·13d ago
<
1
2
...
>